Revvity Inc (RVTY)
116.05
-3.69
(-3.08%)
USD |
NYSE |
Nov 14, 16:00
115.50
-0.55
(-0.47%)
Pre-Market: 09:18
Revvity Cash from Financing (Quarterly): -873.74M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -873.74M |
June 30, 2024 | -26.50M |
March 31, 2024 | -35.01M |
December 31, 2023 | -19.61M |
September 30, 2023 | -586.05M |
June 30, 2023 | -228.27M |
March 31, 2023 | -113.18M |
December 31, 2022 | -76.70M |
September 30, 2022 | -65.64M |
June 30, 2022 | -354.61M |
March 31, 2022 | -164.86M |
December 31, 2021 | -139.02M |
September 30, 2021 | 2.755B |
June 30, 2021 | -257.72M |
March 31, 2021 | 582.99M |
December 31, 2020 | 73.43M |
September 30, 2020 | -155.94M |
June 30, 2020 | -95.77M |
March 31, 2020 | -24.59M |
December 31, 2019 | -251.20M |
September 30, 2019 | 170.13M |
June 30, 2019 | 225.96M |
March 31, 2019 | 5.235M |
December 31, 2018 | -57.27M |
September 30, 2018 | -109.03M |
Date | Value |
---|---|
June 30, 2018 | -25.94M |
March 31, 2018 | 13.01M |
December 31, 2017 | 816.69M |
September 30, 2017 | -15.68M |
June 30, 2017 | -2.586M |
March 31, 2017 | -16.18M |
December 31, 2016 | -62.37M |
September 30, 2016 | 59.80M |
June 30, 2016 | -64.74M |
March 31, 2016 | -47.70M |
December 31, 2015 | -14.71M |
September 30, 2015 | -44.02M |
June 30, 2015 | -23.72M |
March 31, 2015 | -24.69M |
December 31, 2014 | 154.63M |
September 30, 2014 | -47.01M |
June 30, 2014 | -65.14M |
March 31, 2014 | -11.55M |
December 31, 2013 | -15.43M |
September 30, 2013 | -67.76M |
June 30, 2013 | -28.38M |
March 31, 2013 | -42.59M |
December 31, 2012 | 12.11M |
September 30, 2012 | -7.446M |
June 30, 2012 | -38.63M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-873.74M
Minimum
Sep 2024
2.755B
Maximum
Sep 2021
-2.829M
Average
-104.48M
Median
Cash from Financing (Quarterly) Benchmarks
Bionano Genomics Inc | -1.978M |
Avantor Inc | -198.60M |
Bruker Corp | -2.70M |
Azenta Inc | -224.44M |
Harvard Bioscience Inc | 2.104M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 147.88M |
Cash from Investing (Quarterly) | 690.18M |
Free Cash Flow | 564.37M |
Free Cash Flow Per Share (Quarterly) | 1.021 |
Free Cash Flow to Equity (Quarterly) | 812.84M |
Free Cash Flow to Firm (Quarterly) | 127.07M |
Free Cash Flow Yield | 3.94% |